E. Connor, R. Sperling, R. Gelber, P. Kiselev, G. Scott et al., Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment, New England Journal of Medicine, vol.331, issue.18, pp.1173-1180, 1994.
DOI : 10.1056/NEJM199411033311801

E. Cooper, M. Charurat, L. Mofenson, I. Hanson, J. Pitt et al., Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1???Infected Women and Prevention of Perinatal HIV-1 Transmission, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.5, pp.484-494, 2002.
DOI : 10.1097/00042560-200204150-00009

. European-collaborative and . Study, Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.40, issue.3, pp.458-465, 2005.
DOI : 10.1086/427287

J. Ioannidis, E. Abrams, A. Ammann, M. Bulterys, J. Goedert et al., Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mL, The Journal of Infectious Diseases, vol.183, issue.4, pp.539-545, 2001.
DOI : 10.1086/318530

P. Recommendations, Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States, 2005.

J. Delfraissy, Prise en charge thérapeutique des personnes infectées par le VIH. Recommandations du groupe d'expert. Paris: Flammarion Médecine Sciences, 2004.

M. Lallemant, G. Jourdain, L. Coeur, S. Kim, S. Koetsawang et al., A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1, Thailand) Investigators, pp.982-991, 2000.

N. Wade, G. Birkhead, B. Warren, T. Charbonneau, P. French et al., Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus, New England Journal of Medicine, vol.339, issue.20, pp.1409-1414, 1998.
DOI : 10.1056/NEJM199811123392001

L. Mofenson, P. Munderi, D. Watts, R. Balasubramanian, R. Maupin et al., Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316, J Acquir Immune Defic Syndr Am J Obstet Gynecol, vol.30190, issue.11, pp.200-215506, 2002.

F. Lyons, S. Coughlan, C. Byrne, S. Hopkins, W. Hall et al., Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy, AIDS, vol.19, issue.1, pp.63-67, 2005.
DOI : 10.1097/00002030-200501030-00007

P. Stratton, R. Tuomala, R. Abboud, E. Rodriguez, K. Rich et al., Obstetric and Newborn Outcomes in a Cohort of HIV-Infected Pregnant Women: A Report of the Women and Infants Transmission Study, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.20, issue.2, pp.179-186, 1999.
DOI : 10.1097/00042560-199902010-00011

L. Mandelbrot, M. Mayaux, A. Bongain, A. Berrebi, Y. Moudoub-jeanpetit et al., Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts, American Journal of Obstetrics and Gynecology, vol.175, issue.3, pp.661-667, 1996.
DOI : 10.1053/ob.1996.v175.a75478

L. Mandelbrot, L. Chenadec, J. Berrebi, A. Bongain, A. Benifla et al., Perinatal HIV-1 Transmission, JAMA, vol.280, issue.1, pp.55-60, 1998.
DOI : 10.1001/jama.280.1.55

H. Rothschild and P. , Wallet A.); Hôpital Saint-Antoine